v3.26.1
Stock Based Compensation (Tables)
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Summary Of stock-based compensation expense

The following table sets forth the total stock-based compensation expense related to stock options and restricted stock units included in the respective components of operating expenses in the condensed consolidated income statements:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

(in thousands)

 

Unaudited

 

 

Unaudited

 

 

Unaudited

 

 

Unaudited

 

Research and development

 

$

231

 

 

$

429

 

 

$

655

 

 

$

1,113

 

Clinical operations

 

 

64

 

 

 

204

 

 

 

190

 

 

 

297

 

Sales and marketing

 

 

454

 

 

 

467

 

 

 

1,111

 

 

 

918

 

General and administrative

 

 

1,323

 

 

 

1,255

 

 

 

3,075

 

 

 

2,360

 

Total stock-based compensation expense

 

$

2,072

 

 

$

2,355

 

 

$

5,031

 

 

$

4,688